Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis -- Ignore unavailable to you. Want to Upgrade?

To: benwood who wrote (39064)	10/12/2005 2:43:29 PM
From: Elroy Jetson	Respond to of 116555

Since the Bush administration has delayed taking action for years, the amount of anti-virals they can purchase is limited, even though they likely would like far more. Even the Tamiflu they have ordered cannot be delivered until July 2006 and even that will be enough for less than 1/2 of 1% of the population. They claim they have enough treatment for 1% of the population, but this is highly misleading. This is true if they give Amantadine to some, Tamiflu to others and Relenza to others still. If one or more drugs are ineffective, or if multi-drug therapy is needed, there is enough drug stockpiled to treat a tiny fraction of 1% of the population. Their order for only 84,300 Relenza, may indicate that they are waiting for Relenza in injectable vials. In a pandemic, injectable drug would be far more sensible than a drug administered with an inhaler, as Relenza currently is. Let's be honest, people with Bird Flu have problems breathing -- how easy would it be to use an inhaler. .